The latest news, views and analysis from the pharmaceutical industry’s frontline in the war on cancer. Updates on pharmaceutical and biotech oncology pipelines, regulatory decisions and market access news, and how healthcare systems needs to change to tackle one of the world’s biggest killers.
Pfizer had been giving drug free to NHS before decision
Can risk-sharing and real-world evidence can provide traction in treating the brain cancer Glioblastoma?
AI blood test achieves very high accuracy and specificity for detecting ovarian cancer.
Swiss pharma chasing EU licence in NHL and ALL indications
Opdivo performed better than BMS’ Yervoy in clinical trial.